Skip to main content

ESTUDIO DE ALEATORIZACION MENDELIANA DEL SELENIO Y FACTORES RELACIONADOS CON LA DIABETES: UN ENFOQUE INTEGRADOR

PID2019-108973RB-C21

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2019
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre INSTITUTO DE SALUD CARLOS III DE MADRID (ISCIII)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

Repisalud
Publication Artículo científico (JournalArticle)

Multicohort Epigenome-Wide Association Study of All-Cause Cardiovascular Disease and Cancer Incidence: A Cardio-Oncology Approach

  • Domingo-Relloso, Arce
  • Riffo-Campos, Angela L
  • Zhao, Naisi
  • Ayala, Guillermo
  • Haack, Karin
  • Manterola, Carlos
  • Rhoades, Dorothy A
  • Umans, Jason G
  • Fallin, M Daniele
  • Herreros-Martinez, Miguel
  • Pollan-Santamaria, Marina
  • Boerwinkle, Eric
  • Platz, Elizabeth A
  • Jones, Miranda R
  • Bressler, Jan
  • Joehanes, Roby
  • Ryan, Calen P
  • Gonzalez, Juan R
  • Levy, Daniel
  • Belsky, Daniel W
  • Cole, Shelley A
  • Michaud, Dominique S
  • Tellez-Plaza, Maria
  • Navas-Acien, Ana
Background: Emerging evidence reveals a complex relationship between cardiovascular disease (CVD) and cancer, which share common risk factors and biological pathways. Objectives: The aim of this study was to evaluate common epigenetic signatures for CVD and cancer incidence in 3 ethnically diverse cohorts: Native Americans from the SHS (Strong Heart Study), European Americans from the FHS (Framingham Heart Study), and European Americans and African Americans from the ARIC (Atherosclerosis Risk In Communities) study. Methods: A 2-stage strategy was used that included first conducting untargeted epigenome-wide association studies for each cohort and then running targeted models in the union set of identified differentially methylated positions (DMPs). We also explored potential molecular pathways by conducting a bioinformatics analysis. Results: Common DMPs were identified across all populations. In a subsequent meta-analysis, 3 and 1 of those DMPs were statistically significant for CVD only and both cancer and CVD, respectively. No meta-analyzed DMPs were statistically significant for cancer only. The enrichment analysis pointed to interconnected biological pathways involved in cancer and CVD. In the DrugBank database, elements related to 1-carbon metabolism and cancer and CVD medications were identified as potential drugs for target gene products. In an additional analysis restricted to the 950 SHS participants who developed incident CVD, the C index for incident cancer increased from 0.618 (95% CI: 0.570-0.672) to 0.971 (95% CI: 0.963-0.978) when adjusting the models for the combined cancer and CVD DMPs identified in the other cohorts. Conclusions: These results point to molecular pathways and potential treatments for precision prevention of CVD and cancer. Screening based on common epigenetic signatures of incident CVD and cancer may help identify patients with newly diagnosed CVD at increased cancer risk.
Repisalud
Publication Artículo científico (JournalArticle)

metaGWASmanager: a toolbox for an automated workflow from phenotypes to meta-analysis in GWAS consortia

  • Rodriguez-Hernandez, Zulema
  • Gorski, Mathias
  • Tellez-Plaza, Maria
  • Schlosser, Pascal
  • Wuttke, Matthias
Summary: This article introduces the metaGWASmanager, which streamlines genome-wide association studies within large-scale meta-analysis consortia. It is a toolbox for both the central consortium analysis group and participating studies to generate homogeneous phenotypes, minimize unwanted variability from inconsistent methodologies, ensure high-quality association results, and implement time-efficient quality control workflows. The toolbox features a plug-in-based approach for customization of association testing. Results: The metaGWASmanager toolbox has been successfully deployed in both the CKDGen and MetalGWAS Initiative consortia across hundreds of participating studies, demonstrating its effectiveness in GWAS analysis optimization by automating routine tasks and ensuring the value and reliability of association results, thus, ultimately promoting scientific discovery. We provide a simulated data set with examples for script customization so that readers can reproduce the pipeline at their convenience. Availability and implementation: GitHub: https://github.com/genepi-freiburg/metaGWASmanager.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Tesis doctoral (DoctoralThesis)

The Role of Selenium in Type 2 Diabetes: an Integrative Genomic Study to Inform Precision Medicine

  • Rodríguez Hernández, Zulema
[ES] El selenio es un oligoelemento esencial con funciones antioxidantes importantes en los humanos. Sin embargo, su posible papel en las enfermedades relacionadas con la diabetes sigue siendo un tema de debate. Objetivos. Primero, estudiar los efectos potenciales del selenio en la prediabetes con la edad. Segundo, desarrollar una caja de herramientas para realizar estudios de asociación del genoma completo (GWAS) y meta-análisis dentro de consorcios. Tercero, evaluar los determinantes (ambientales y genéticos) de diferentes biomarcadores de selenio. Cuarto, evaluar si los niveles de biomarcadores de selenio están causalmente relacionados con la diabetes y sus complicaciones. Principalmente se trabajó con la cohorte Aragon Workers Health Study (AWHS), un cohorte española formada por adultos de mediana edad. El selenio en suero y las especies de selenio (glutatión peroxidasa [GPx], selenoproteína P [SeP], selenoalbúmina [SeAlb] y selenometabolitos totales [Se-metabolitos]) se midieron mediante ICP-QQQ-MS, y el selenio en sangre y orina mediante ICP-MS. Los análisis genéticos se realizaron con SNPs imputados con TOPMed. Para abordar el primer objetivo, se utilizó el estudio Seniors ENRICA-2 para representar a la población anciana, y el de NHANES 2011-2018 para validar los hallazgos. Para el segundo objetivo, empleamos R, Bash y Python para personalizar la caja de herramientas basada en el concepto plug-in. Para el tercer objetivo, estimamos la contribución relativa de los factores genéticos y no genéticos en AWHS. Para evaluar los determinantes no genéticos, se construyó una puntuación de estilo de vida saludable. Para analizar los determinantes genéticos se realizaron aproximaciones de genes candidatos y GWAS. Resumimos el efecto de la genética mediante "scores" poligénicos. Finalmente, para el cuarto objetivo, estudiamos el potencial papel causal de los biomarcadores de selenio en enfermedades relacionadas con la diabetes a través del estudio de dosis-respuesta genéticas, colocalización y aleatorización mendeliana. El nivel alto de selenio en sangre se asoció positivamente con la resistencia a la insulina y la función de las células ß solo en adultos de mediana edad, sugiriendo que la resistencia a la insulina vinculada al selenio potencialmente desencadena una mejora en la función de las células ß en individuos más jóvenes. La caja de herramientas metaGWASmanager se desarrolló y aplicó con éxito en el consorcio CKDGen (>2 millones de individuos y >1,800 GWAS). Se observaron asociaciones positivas e inversas entre un estilo de vida saludable (p.ej., actividad física) y hábitos no saludables (p.ej., fumar), respectivamente, con el selenio en suero, SeAlb y Se-metabolitos. Para todos los marcadores de selenio, identificamos variantes genéticas independientes anotadas a genes que participan en la regulación del ritmo circadiano, sistema inmunológico y vías relacionadas con receptores y transportadores. La genética explicó una mayor proporción de variabilidad en los niveles de biomarcadores de selenio (~20%) en comparación con los factores no genéticos (~2%). En general, la información genética respalda que el aumento sérico de la GPx y de los Se-metabolitos podría tener efectos perjudiciales sobre la prediabetes, la enfermedad renal y la presencia de placa. La SeP sérica se relacionó positivamente con la enfermedad renal. Por el contrario, el aumento de selenio sérico y de la SeP fue beneficioso para la enfermedad aterosclerótica. Hemos desarrollado nuevas herramientas bioinformáticas para la explotación de la variación genómica en estudios epidemiológicos y consorcios. Nuestros hallazgos respaldan el papel del selenio en el riesgo cardiometabólico y proporcionan una base para desarrollar nuevas estrategias para la prevención y el control de las complicaciones de la diabetes., [CA] El seleni és un oligoelement essencial comercialitzable amb funcions antioxidants importants en els humans. Malgrat això, el seu possible paper en malalties relacionades amb la diabetes segueix en debat. Objectius. Primer, estudiar els efectes del seleni en la prediabetis segons l'edat. Segon, desenvolupar eines per realitzar estudis d'associació del genoma complet (GWAS) i metaanàlisi dins de consorcis. Tercer, avaluar els determinants (ambientals i genètics) de diferents biomarcadors de seleni. Quart, avaluar si els nivells de biomarcadors de seleni estan causalment relacionats amb la diabetis i les seues complicacions. En la major part d'aquesta tesi s'ha treballat amb "Aragon Workers Health Study" (AWHS), una cohort espanyola formada per adults de mitjana edat. El seleni en sèrum i les espècies de seleni (glutatió peroxidasa [GPx], selenoproteïna P [SeP], selenoalbúmina [SeAlb] i selenometabolits totals [Se-metabolits]) es van mesurar mitjançant ICP-QQQ-MS, i el seleni en sang i orina mitjançant ICP-MS. Les anàlisis genètiques es van realitzar amb SNPs imputats amb TOPMed. Per abordar el primer objectiu, es va utilitzar l'estudi Seniors ENRICA-2 per representar la població anciana, i el de NHANES 2011-2018 per validar els resultats. Per al segon objectiu, ferem servir R, Bash i Python per personalitzar les ferramentes basant-nos en el concepte de plug-in. Per al tercer objectiu, estimàrem la contribució relativa dels factors genètics i no genètics en AWHS. Per avaluar els determinants no genètics, es va construir una puntuació d'estil de vida saludable, considerant factors sociodemogràfics i la dieta. Per analitzar els determinants genètics es van fer aproximacions de gens candidats i GWAS. Vam resumir l'efecte de la genètica mitjaçant "scores" poligènics. Finalment, per al quart objectiu, estudiarem el potencial paper causal dels biomarcadors de seleni en malalties relacionades amb la diabetis mitjaçant l'estudi de dosi-resposta genètica, colocalització i aleatorització mendeliana. El nivell elevat de seleni en sang es va associar positivament amb la resistència a la insulina i la funció de les cèl·lules ß només en adults de mitjana edat (AWHS), suggerint que la resistència a la insulina vinculada al seleni potencialment desencadena una millora en la funció de les cèl·lules ß en individus més joves. La caixa d'eines metaGWASmanager es va desenvolupar i aplicar amb èxit al consorci CKDGen (>2 milions d'individus i >1,800 GWAS). Es van observar associacions positives i inverses entre un estil de vida saludable (p.ex., activitat física) i hàbits no saludables (p.ex., fumar), respectivament, amb el seleni en sèrum, SeAlb i Se-metabolits. Per a tots el marcadors de seleni, identificarem variants genètiques independents anotades a gens que participen en la regulació del ritme circadià, sistema immunològic i vies relacionades amb receptors i transportadors. La genètica va explicar una proporció més gran de variabilitat en els nivells de biomarcadors de seleni (~20%) en comparació amb els factors no genètics (~2%). En general, la informació genètica recolza que l'augment sèric de la GPx i dels Se-metabolits podria tenir efectes perjudicials sobre la prediabetis, la malaltia renal i la presència de placa. La SeP sèrica es va relacionar positivament amb la malaltia renal. Per contra, l'augment de seleni sèric i de la SeP va ser potencialment beneficiós per a la malaltia ateroscleròtica. Hem desenvolupat noves eines bioinformàtiques per a l'explotació de la variació genòmica en estudis epidemiològics i consorcis. Les nostres troballes donen suport, en general, al paper del seleni en el risc cardiometabòlic i proporcionen una base per desenvolupar noves estratègies i intervencions per a la prevenció i el control de les complicacions de la diabetis., [EN] Selenium is a marketed essential trace element with important antioxidant functions in humans. However, its potential role in diabetes-related diseases remains a subject of debate. Objectives. First, to study the potential effects of selenium on prediabetes by age. Second, to develop a toolbox for conducting Genome-wide association studies (GWAS) within large-scale meta-analysis consortia. Third, to evaluate determinants (environmental and genetics) of different selenium biomarkers. Fourth, to evaluate if selenium biomarker levels causally relate to diabetes and its complications. We mainly work with the Aragon Workers Health Study (AWHS), a Spanish cohort made of middle-aged adults. Serum selenium and selenium species (glutathione peroxidase [GPx], selenoprotein P [SeP], selenoalbumin [SeAlb] and total selenometabolites [Se-metabolites]) were measured by ICP-QQQ-MS, and selenium in blood and urine by ICP-MS. Genetics analyses were performed based on TOPMed imputable SNPs. To address the first goal, the Seniors ENRICA-2 study was used to represent the elderly population, and 2011-2018 NHANES to validate findings. For the second objective, we employed R, Bash, and Python to tailor the plug-in concept. For the third objective, we studied the relative contribution of genetic and non-genetic factors in AWHS. To assess non-genetic determinants, we considered sociodemographic, dietary and a comprehensive healthy lifestyle score was constructed. To evaluate genetic determinants, candidate-gene and GWAS approaches were performed. We summarized the joint effect of genetics using polygenic scores. Finally, for the fourth objective, we studied the potential causal effect of selenium biomarkers on diabetes-related diseases through the study of genetic dose-responses, colocalization and mendelian randomization. Elevated blood selenium concentrations were positively associated to insulin resistance and ß-cell function only in middle-age adults (AWHS), suggesting that selenium-linked insulin resistance potentially triggers enhanced ß-cell function in younger individuals, diminishing with age. The metaGWASmanager toolbox was developed and successfully applied in the CKDGen (>2 million individuals and >1,800 GWAS). Positive and inverse associations were observed between healthy lifestyle (e.g. physical activity) and unhealthy habits (e.g., smoking,), respectively, with serum selenium, SeAlb and Se-metabolites. We also identified several independent genetic variants associated with all selenium markers annotated to genes participating in circadian rhythm regulation, immune system processes, signaling and receptor- and transporter-related pathways. Genetics contributed a greater proportion of variability in selenium biomarkers levels (~20%) compared to non-genetic factors (~2%). The exploitation of genetic information, overall, supports that increased serum GPx and Se-metabolites might have detrimental effects on prediabetes and diabetes complications by increasing renal disease and the presence of atherosclerosis plaque. Serum SeP, was positively related to renal disease. Conversely, increased serum selenium and SeP was potentially beneficial for atherosclerotic disease. We have developed novel bioinformatics tools for the exploitation of genomic variation in epidemiologic studies and consortia. Our findings support, overall, the role of selenium on cardiometabolic risk, and provide a basis for developing new strategies and interventions for the prevention and control of diabetes complications., I was awarded two notable grants, one from Spanish and another from Europe, which have been essential in supporting this thesis: Predoctoral national FPI (Research Staff Training) grant PID2019-108973RB-C21 from the Ministerio de Ciencia e Innovación, National Research Agency (Spain), which funds this thesis (August 2021- June 2023) and MBO (European Molecular Biology Organization) scientific exchange grant number 10351, July 2023, for conducting a research stay
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Association of miR-126-3p, miR-1260b and miR-374a-5p with the incidence of heart failure in a population-based cohort: the Hortega Follow-Up Study

  • Grau-Perez, Maria
  • Martinez-Arroyo, Olga
  • Rubia-Martinez, Marta
  • Flores-Chova, Ana
  • Rodríguez-Hernández, Zulema
  • Fernández-Navarro, Pablo
  • Gonzalez-Neira, Anna
  • Alonso, María Rosario
  • Pita, Guillermo
  • Pineda, Silvia
  • Martin-Escudero, Juan C.
  • Redon, Josep
  • Tellez-Plaza, Maria
  • Cortes, Raquel
  • Guasque Ortega, Ana|||0000-0002-2900-8466
[EN] Background: Circulating microRNAs (miRNAs) are emerging markers for cardiovascular prevention and control. miRNAs associated to vascular damage are candidates to play a causal role in the microvascular dysfunction of heart failure (HF). The aim was to evaluate the observational and causal (Mendelian randomization) association of miRNAs related with vascular alterations (miR-126-3p, miR-1260b and miR-374a-5p) with HF incidence in a sample from the general population. Methods: Plasma miRNAs levels were measured in 985 Hortega Study participants using real time quantitative polymerase chain reaction (RT-qPCR). Single nucleotide polymorphisms (SNPs) were genotyped with the TOPMED imputable Illumina GSA array. We identified genetic instrumental variables for miR-126-3p (33 SNPs), miR-1260b (22 SNPs) and miR-374a-5p (35 SNPs) and run several Mendelian randomization approaches. Results: The hazard ratio (95 % confidence interval) of HF by a 10-fold increase in miR-126-3p, miR-1260b and miR-374a-5p was 1.53 (1.09, 2.14), 1.38 (1.03, 1.86), and1.30 (1.09, 1.57), respectively. The corresponding rate differences were 9.7 (-0.1, 19.5), 12.0 (0.4, 23.6) and 9.1 (1.2, 17.1) per 10000 person-years. In flexible dose-response analysis, increased miRNAs levels were associated with higher HF risk, both in the relative and additive scale. In Mendelian randomization analysis, consistently suggestive positive causal associations were found with HF for increased miR-126-3p and miR-1260b levels, but not for miR-374a-5p. Conclusions: In observational analysis, miR-126-3p, miR-1260b and miR-374a-5p levels were positively associ-ated with HF incidence. Mendelian randomization analysis supported a causal role for miR-126-3p and miR-1260b, thus suggesting a potential use as prognostic and therapeutic targets for HF prevention and control., We thank Nuria Alvarez y Belen Herraez, from the Human Genotyping-CEGEN Unit, at the National Center for Cancer Research from the Carlos III Health Institutes, in Madrid (Spain) , for their contribution in the genotyping procedure. This research was funded by health sciences research grants from the Carlos III Health Institute (grant numbers PI19/01796 to J.R.; PI21/00249 and CP22/00069 to R.C.; PI23/01179 to A.O.; FI20/00096 to O.M.-A; and FI22/00032 to A.F.-C.; PI15/00071 and PI22CIII/00029 to M.T.-P.) . This work was also sup-ported by the State Agency for Research (PID2019-108973RB-C21 to M. T.-P.) . Grant IJC2020-045308-I, Juan de la Cierva Incorporacion funded by MCIN/AEI/10.13039/501100011033 and by ESF-Investing in Your Future (to A.O.) ; CNS2022-136175, Research Consolidation Grants, funded by MCIN/AEI/10.13039/501100011033 and European Union "Next Generation EU"/PRTR" (to R.C) .; FP7-HEALTH 11 (grant number no 278249) . It was co-funded by the European Union (the European Regional Development Fund (ERDF) and the European Social Fund (FSE) ) ; CIBER of Obesity and Nutrition Physiopathology (CIBEROBN) (grant numbers CIBER-02-08-2009, CB06/03 and CB12/03/30016) . CIBER of Cardiovascular diseases (CIBERCV) (grant number CB16/11/00261) . CIBEROBN and CIBERCV are co-funded with European Funds for Regional Development (FEDER) , and IDIFEDER/2021/072, CIAICO/2022/181 and INVEST/2023/180 from the Generalitat Valenciana of Spain. Z.R.-H. received a fellowship associated to a Spain National Investigation Agency project (PRE2020-093926) . The genotyping service was carried out at the Genotyping Unit-CEGEN in the Spanish Na-tional Cancer Research Centre (CNIO) , supported by Instituto de Salud Carlos III (ISCIII) , Ministerio de Ciencia e Innovacion. CEGEN is part of the initiative IMPaCT GEN oMICA (IMP/00009) cofunded by ISCIII and the European Regional Development Fund (ERDF)
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Metabolomic patterns, redox-related genes and metals, and bone fragility endpoints in the Hortega Study

  • Galvez-Fernandez, Marta
  • Rodríguez-Hernández, Zulema
  • Grau-Perez, Maria
  • Chaves, F. Javier
  • García-García, Ana Bárbara
  • Amigo, Nuria
  • Monleón, Daniel
  • Garcia-Barrera, Tamara
  • Gomez-Ariza, Jose L.
  • Briongos-Figuero, Laisa S.
  • Perez-Castrillon, Jose L.
  • Redón, Josep
  • Tellez-Plaza, Maria
  • Martin-Escudero, Juan C.
[EN] Background: The potential joint influence of metabolites on bone fragility has been rarely evaluated. We assessed the association of plasma metabolic patterns with bone fragility endpoints (primarily, incident osteoporosisrelated bone fractures, and, secondarily, bone mineral density BMD) in the Hortega Study participants. Redox balance plays a key role in bone metabolism. We also assessed differential associations in participant subgroups by redox-related metal exposure levels and candidate genetic variants. Material and methods: In 467 participants older than 50 years from the Hortega Study, a representative sample from a region in Spain, we estimated metabolic principal components (mPC) for 54 plasma metabolites from NMR-spectrometry. Metals biomarkers were measured in plasma by AAS and in urine by HPLC-ICPMS. Redoxrelated SNPs (N = 341) were measured by oligo-ligation assay. Results: The prospective association with incident bone fractures was inverse for mPC1 (non-essential and essential amino acids, including branched-chain, and bacterial co-metabolites, including isobutyrate, trimethylamines and phenylpropionate, versus fatty acids and VLDL) and mPC4 (HDL), but positive for mPC2 (essential amino acids, including aromatic, and bacterial co-metabolites, including isopropanol and methanol). Findings from BMD models were consistent. Participants with decreased selenium and increased antimony, arsenic and, suggestively, cadmium exposures showed higher mPC2-associated bone fractures risk. Genetic variants annotated to 19 genes, with the strongest evidence for NCF4, NOX4 and XDH, showed differential metabolic-related bone fractures risk. Conclusions: Metabolic patterns reflecting amino acids, microbiota co-metabolism and lipid metabolism were associated with bone fragility endpoints. Carriers of redox-related variants may benefit from metabolic interventions to prevent the consequences of bone fragility depending on their antimony, arsenic, selenium, and, possibly, cadmium, exposure levels., Funding statement The work was funded by theo State Research Agency at the Ministerio de Ciencia Innovacion y Universidades of Spain (PID2019-108973RB-C21, PID2019-108973RB-C22 and PCIN-2017-117) ; the Generalitat Valenciana of Spain (IDIFEDER/2021/072, GRUPOS 03/101, PROMETEO/2009/029, ACOMP/2013/039, IDIFEDER/2021/072 and GRISOLIAP/2021/119) ; the EU Joint Programming Initiative Healthy Diet Healthy Life (HDHL) GUTMOM (INTIMIC-085) ; the Strategic Action for Research in Health sciences [CP12/03080, PI15/00071, PI10/0082, PI13/01848, PI14/00874, PI16/01402, PI17/00544 and PI11/00726] ; CIBER Fisiopatologia Obesidad y Nutricion (CIBEROBN) (CIBER-02-08-2009, CB06/03 and CB12/03/30016) ; the Castilla-Leon Government (GRS/279/A/08) and European Network of Excellence Ingenious Hypercare (EPSS-037093) from the European Commission. The Strategic Action for Research in Health sciences and CIBEROBN are initiatives from Carlos III Health Institute Madrid and co-funded with European Funds for Regional Development (FEDER) . M.G-P received the support of a fellowship from "la Caixa" Foundation (ID 100010434, fellowship code LCF/BQ/IN18/11660001) . The funding bodies had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Gene-environment interaction analysis of redox-related metals and genetic variants with plasma metabolic patterns in a general population from Spain: The Hortega Study

  • Galvez-Fernandez, Marta
  • Domingo-Relloso, Arce
  • Rodríguez-Hernández, Zulema
  • Gonzalez-Marrachelli, Vannina
  • Grau-Perez, Maria
  • Morales-Tatay, José M.
  • Amigo, Nuria
  • Garcia-Barrera, Tamara
  • Gomez-Ariza, Jose L.
  • Chaves, F. Javier
  • Garcia-Garcia, Ana Barbara
  • Melero, Rebeca
  • Tellez-Plaza, Maria
  • Sanchez Saez, Francisco|||0000-0002-3011-9884
  • Tarazona, Sonia|||0000-0001-5346-1407
[EN] Background: Limited studies have evaluated the joint influence of redox-related metals and genetic variation on metabolic pathways. We analyzed the association of 11 metals with metabolic patterns, and the interacting role of candidate genetic variants, in 1145 participants from the Hortega Study, a population-based sample from Spain. Methods: Urine antimony (Sb), arsenic, barium (Ba), cadmium (Cd), chromium (Cr), cobalt (Co), molybdenum (Mo) and vanadium (V), and plasma copper (Cu), selenium (Se) and zinc (Zn) were measured by ICP-MS and AAS, respectively. We summarized 54 plasma metabolites, measured with targeted NMR, by estimating metabolic principal components (mPC). Redox-related SNPs (N = 291) were measured by oligo-ligation assay. Results: In our study, the association with metabolic principal component (mPC) 1 (reflecting non-essential and essential amino acids, including branched chain, and bacterial co-metabolism versus fatty acids and VLDL subclasses) was positive for Se , Zn, but inverse for Cu, arsenobetaine-corrected arsenic (As) and Sb. The association with mPC2 (reflecting essential amino acids, including aromatic , bacterial co-metabolism) was inverse for Se, Zn and Cd. The association with mPC3 (reflecting LDL subclasses) was positive for Cu, Se and Zn, but inverse for Co. The association for mPC4 (reflecting HDL subclasses) was positive for Sb, but inverse for plasma Zn. These associations were mainly driven by Cu and Sb for mPC1; Se, Zn and Cd for mPC2; Co, Se and Zn for mPC3; and Zn for mPC4. The most SNP-metal interacting genes were NOX1, GSR, GCLC, AGT and REN. Co and Zn showed the highest number of interactions with genetic variants associated to enriched endocrine, car-diovascular and neurological pathways. Conclusions: Exposures to Co, Cu, Se, Zn, As, Cd and Sb were associated with several metabolic patterns involved in chronic disease. Carriers of redox-related variants may have differential susceptibility to metabolic alterations associated to excessive exposure to metals., This work was supported by the Strategic Action for Research in Health sciences [CP12/03080, PI15/00071, PI10/0082, PI13/01848, PI14/00874, PI16/01402, PI21/00506 and PI11/00726] , CIBER Fisio-patologia Obesidad y Nutricion (CIBEROBN) (CIBER-02-08-2009, CB06/03 and CB12/03/30,016) , the State Agency for Research (PID2019-108973RB-C21 and C22) , the Valencia Government (GRU-POS 03/101; PROMETEO/2009/029 and ACOMP/2013/039, IDI-FEDER/2021/072 and GRISOLIAP/2021/119) , the Castilla-Leon Government (GRS/279/A/08) and European Network of Excellence Ingenious Hypercare (EPSS-037093) from the European Commission. The Strategic Action for Research in Health sciences, CIBERDEM and CIBEROBN are initiatives from Carlos III Health Institute Madrid and co-funded with European Funds for Regional Development (FEDER) . The State Agency for Research and Carlos III Health Institute belong to the Spanish Ministry of Science and Innovation. ADR received the support of a fellowship from "la Caixa"Foundation (ID 100010434) (fellowship code "LCF/BQ/DR19/11740016") . MGP received the support of a fellowship from "la Caixa" Foundation (ID 100010434, fellowship code LCFLCF/BQ/DI18/11660001) . The funding bodies had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Omics feature selection with the extended SIS R package: identification of a body mass index epigenetic multimarker in the Strong Heart Study

  • Domingo-Relloso, Arce
  • Feng, Yang
  • Rodríguez-Hernández, Zulema
  • Haack, Karin
  • Cole, Shelley A.
  • Navas-Acien, Ana
  • Tellez-Plaza, Maria
  • Bermudez, Jose D.
[EN] The statistical analysis of omics data poses a great computational challenge given its ultra-high dimensional nature and frequent between-features correlation. In this work, we extended the Iterative Sure Independence Screening (ISIS) algorithm by pairing ISIS with elastic-net (Enet) and two versions of adaptive Enet (AEnet and MSAEnet) to efficiently improve feature selection and effect estimation in omics research. We subsequently used genome-wide human blood DNA methylation data from American Indians of the Strong Heart Study (N=2,235 participants), measured in 1989-1991, to compare the performance (predictive accuracy, coefficient estimation and computational efficiency) of SIS-paired regularization methods to Bayesian shrinkage and traditional linear regression to identify epigenomic multi-marker of body mass index. ISIS-AEnet outperformed the other methods in prediction. In biological pathway enrichment analysis of genes annotated to BMI-related differentially methylated positions, ISIS-AEnet captured most of the enriched pathways in common for at least two of all the evaluated methods. ISIS-AEnet can favor biological discovery because it identifies the most robust biological pathways while achieving an optimal balance between bias and efficient feature selection. In the extended SIS R package, we also implemented ISIS paired with Cox and logistic regression for time-to-event and binary endpoints, respectively, and bootstrap confidence intervals for the estimated regression coefficients., The Strong Heart Study is funded by grants from the National Heart, Lung, and Blood Institute (NHLBI) (contracts 75N92019D00027, 75N92019D00028, 75N92019D00029, and 75N92019D00030) and previous NHLBI grants (R01HL090863, R01HL109315, R01HL109301, R01HL109284, R01HL109282, and R01HL109319) and cooperative agreements (U01HL41642, U01HL41652, U01HL41654, U01HL65520, and U01HL65521) and by the National Institute of Environmental Health Sciences (grants R01ES021367, R01ES025216, P42ES033719, and P30ES009089). A.D.-R. was supported by a fellowship from the "la Caixa" Foundation (ID100010434; fellowship code LCF/BQ/DR19/11740016). M.T.-P. was supported by Strategic Action for Research in Health Sciences (grant PI15/00071), an initiative from the Instituto de Salud Carlos III and the Spanish Ministry of Science and Innovation and co funded by the European Funds for Regional Development, the Third AstraZeneca Award for Spanish Young Researchers, and the State Agency for Research (grant PID2019-108973RB-C21).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Selenium and impaired physical function in US and Spanish older adults

  • García-Esquinas, E.
  • Carrasco-Rios, M.
  • Ortolá, R.
  • Sotos Prieto, M.
  • Pérez-Gómez, Beatriz
  • Gutiérrez-González, E.
  • Banegas, José Ramón
  • Queipo, R.
  • Omedo, P.
  • Gil, F.
  • Tellez-Plaza, M.
  • Navas-Acien, Ana
  • Pastor-Barriuso, Roberto
  • Rodriguez-Artalejo, Fernando
[Background]: Selenium (Se) is a trace element with a narrow safety margin., [Objectives]: To evaluate the cross-sectional and longitudinal dose-response association between Se exposure and measures of impaired physical function and disability in older adults., [Design]: NHANES 2011–2014 cross-sectional (US, n = 1733, age ≥60 years) and Seniors-ENRICA-2 2017–2019 cross-sectional and longitudinal (Spain, n = 2548 and 1741, respectively, age ≥65 years) data were analyzed. Whole blood and serum Se levels were measured using inductively coupled plasma-mass spectrometry. Lower-extremity performance was assessed with the Short Physical Performance Battery, and muscle weakness with a dynamometer. Incident mobility and agility limitations, and disability in instrumental activities of daily living (IADL) were ascertained with standardized questionnaires. Analyses were adjusted for relevant confounders, including physical activity. Results across studies were pooled using random-effects meta-analysis., [Results]: Meta-analyzed odds ratios (95% confidence interval) per log2 increase in whole blood Se were 0.54 (0.32; 0.76) for weakness, 0.59 (0.34; 0.83) for impaired lower-extremity performance, 0.48 (0.31; 0.68) for mobility limitations, 0.71 (0.45; 0.97) for agility limitations, and 0.34 (0.12; 0.56) for disability in at least one IADL. Analyses for serum Se in NHANES showed similar results. Findings suggest the inverse association with grip strength is progressive below 140 μg/L (p-value for non-linear trend in the Seniors-ENRICA-2 study = 0.13), and above 140 μg/L (p-value for non-linear trend in NHANES = 0.11). In the Seniors-ENRICA-2 cohort, with a 2.2 year follow-up period, a doubling in baseline Se levels were associated with a lower incidence of weakness [odds ratio (95% confidence interval): 0.45 (0.22; 0.91)], impaired lower-extremity performance [0.63 (0.32; 1.23)], mobility [0.43 (0.21; 0.91)] and agility [0.38 (0.18; 0.78)] limitations., [Discussion]: In US and Spanish older adults, Se concentrations were inversely associated with physical function limitations. Further studies are needed to elucidate underlying mechanisms., This work has been supported by grants PI18/287 and 16/609 from the Instituto de Salud Carlos III, State Secretary of R + D + I, and FEDER/FSE; and by PID2019-108973RB-C21/C22 from the State Secretary of R + D + I., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Association of single and joint metals with albuminuria and estimated glomerular filtration longitudinal change in middle-aged adults from Spain: The Aragon workers health study

  • Grau-Perez, M.
  • Domingo-Relloso, A.
  • García-Barrera, T.
  • Gómez-Ariza, J. L.
  • León-Latre, Montserrat
  • Casasnovas, J. A.
  • Moreno-Franco, B.
  • Laclaustra, M.
  • Guallar, E.
  • Navas-Acien, A.
  • Pastor-Barriuso, R.
  • Redon, J.
  • Tellez-Plaza, M.
The nephrotoxicity of low-chronic metal exposures is unclear, especially considering several metals simultaneously. We assessed the individual and joint association of metals with longitudinal change in renal endpoints in Aragon Workers Health Study participants with available measures of essential (cobalt [Co], copper [Cu], molybdenum [Mo] and zinc [Zn]) and non-essential (As, barium [Ba], Cd, chromium [Cr], antimony [Sb], titanium [Ti], uranium [U], vanadium [V] and tungsten [W]) urine metals and albumin-to-creatinine ratio (ACR) (N = 707) and estimated glomerular filtration rate (eGFR) (N = 1493) change. Median levels were 0.24, 7.0, 18.6, 295, 3.1, 1.9, 0.28, 1.16, 9.7, 0.66, 0.22 μg/g for Co, Cu, Mo, Zn, As, Ba, Cd, Cr, Sb, Ti, V and W, respectively, and 52.5 and 27.2 ng/g for Sb and U, respectively. In single metal analysis, higher As, Cr and W concentrations were associated with increasing ACR annual change. Higher Zn, As and Cr concentrations were associated with decreasing eGFR annual change. The shape of the longitudinal dose-responses, however, was compatible with a nephrotoxic role for all metals, both in ACR and eGFR models. In joint metal analysis, both higher mixtures of Cu–Zn–As–Ba–Ti–U–V–W and Co–Cd–Cr–Sb–V–W showed associations with increasing ACR and decreasing eGFR annual change. As and Cr were main drivers of the ACR change joint metal association. For the eGFR change joint metal association, while Zn and Cr were main drivers, other metals also contributed substantially. We identified potential interactions for As, Zn and W by other metals with ACR change, but not with eGFR change. Our findings support that Zn, As, Cr and W and suggestively other metals, are nephrotoxic at relatively low exposure levels. Metal exposure reduction and mitigation interventions may improve prevention and decrease the burden of renal disease in the population.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Differential association of selenium exposure with insulin resistance and ß-cell function in middle age and older adults

  • Rodriguez-Hernandez, Zulema
  • Bel-Aguilar, Javier
  • Moreno-Franco, Belen
  • Grau-Perez, Maria
  • Redon, Josep
  • Gomez-Ariza, Jose L.
  • Garcia-Barrera, Tamara
  • Olmedo, Pablo
  • Gil, Fernando
  • Cenarro, Ana
  • Civeira, Fernando
  • Puzo, Jose
  • Casasnovas, Jose A.
  • Banegas, Jose R.
  • Sotos-Prieto, Mercedes
  • Ortola, Rosario
  • Laclaustra, Martin
  • Rodriguez-Artalejo, Fernando
  • Garcia-Esquinas, Esther
  • Tellez-Plaza, Maria
  • Pastor-Barriuso, Roberto
Objective To assess whether the role of selenium on pre-diabetes is differential by age, given comorbidities and decreased β-cell function in older adults. Research design and methods We evaluated the cross-sectional association of blood selenium with the homeostatic model assessment for insulin resistance (HOMA-IR) and β-cell function (HOMA-β) in middle-aged (Aragon Workers Health Study [AWHS], N = 1186), and older (Seniors ENRICA [Study on Nutrition and Cardiovascular Risk in Spain]-2 [SEN-2], N = 915) diabetes-free adults. A subsample of participants from AWHS (N = 571) and SEN-2 (N = 603) had glucose and insulin repeated measurements for longitudinal analysis. We validated the cross-sectional dose–response associations in the 2011–2018 National Health and Nutrition Examination Survey (NHANES, N = 1317 middle age and N = 960 older) participants. Selenium was measured in whole blood with ICP-MS in AWHS, SEN-2 and NHANES. Results The cross-sectional geometric mean ratios (95% confidence intervals) per two-fold selenium increase were 1.09 (1.01, 1.19) for HOMA-IR and 1.15 (1.06, 1.24) for HOMA-β in AWHS; and 1.13 (0.98, 1.31) and 1.03 (0.90, 1.18), in SEN-2. The cross-sectional dose-response associations were consistent in NHANES, with mostly increasingly positive trends for both HOMA endpoints in younger adults and a plateau at levels >~150 μg/L in older adults. The longitudinal dose–response consistently showed positive associations at high selenium dose for both HOMA endpoints in the younger, but not the older, study population. Conclusions Increased blood selenium was associated with increased insulin resistance and β-cell function in middle-aged, but not in older individuals, especially for β-cell function. The results suggest that selenium-associated insulin resistance might induce compensatory increased β-cell function at younger ages, being this compensatory capacity decreased with aging.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Non-genetic and genetic determinants of serum selenium and selenium species in the Aragon Workers Health Study

  • Rodriguez-Hernandez, Zulema
  • Paredes-Douton, Anabel
  • Galvez-Fernandez, Marta
  • Grau-Perez, Maria
  • Sotos-Prieto, Mercedes
  • Rentero-Garrido, Pilar
  • Gonzalez-Estecha, Montserrat
  • Llorente-Ballesteros, Maria Teresa
  • Gomez-Ariza, Jose L.
  • Callejon-Leblic, Belen
  • Fernandez-Navarro, Pablo
  • Laclaustra, Martin
  • Cenarro, Ana
  • Civeira, Fernando
  • Glabonjat, Ronald A.
  • Monleon, Daniel
  • Pastor-Barriuso, Roberto
  • Moreno-Franco, Belen
  • Garcia-Barrera, Tamara
  • Tellez-Plaza, Maria
Understanding potential determinants of selenium biomarkers can help to unravel selenium health effects. We evaluated the contribution of non-genetic (sociodemographic and lifestyle) and genetic factors to serum selenium biomarkers and selenium species (quantified as selenium) including selenium in glutathione peroxidase (GPx), selenoprotein P (SeP), selenoalbumin (SeAlb) and total selenometabolites (Se-metabolites) in the Aragon Workers Health Study (AWHS), a predominantly male cohort of car assembly factory workers in Spain. Total serum selenium and selenium species were measured by HPLC/ICP-QQQ-MS in 1624 AWHS participants. Blood and urine selenium, measured by ICP-MS, were available in a subset. A Healthy Lifestyle Score (HLS) included Mediterranean diet, physical activity, smoking, BMI and alcohol intake. Candidate gene and genome-wide discovery analyses (CGA and GDA, respectively) were based on TOPMed imputed SNPs. In sex and age-adjusted models, overall HLS, physical activity, and specific foods intake showed positive associations with serum total selenium, SeAlb and Se-metabolites concentrations. The associations between smoking status and BMI with total serum selenium; age, smoking status, BMI and meat intake with SeAlb; and smoking status with Se-metabolites, were inverse. In the GDA, we identified 20, 24, 21, 26, 16, 20 and 68 independent genetic loci for serum total selenium, GPx, SeP, SeAlb, Se-metabolites, and total blood and urine selenium, respectively, with some overlapping genes also relevant in the CGA. Enrichment analysis pointed to biological pathways including circadian rhythm regulation, immune system processes, signaling and receptor- and transporter-related pathways. The explained variability of selenium markers ranged from 15 % for SeP to 21 % for SeAlb and from 0.2 % for SeP to 3.5 % for SeAlb in environmental determinants-adjusted models with and without the specific selenium biomarker polygenic score, respectively. While the genetic contribution is substantial, selenium status might be influenced by reinforced healthy lifestyle interventions. Follow-up genetic studies to evaluate selenium health consequences are granted.